Back to Companies who have applied for FDA Drug Approval

FDA Drug Approval Applications Sponsored by LILLY

Application NumberDrugs/ProductsApplication TypeMost Recent Label Available FlagCurrent Patent FlagAction TypeChemical TypeTher PotentialOrphan Code
000159 New Drug Application Approval
000734 New Drug Application Approval
002139 New Drug Application Approval
004039 New Drug Application Approval
004040 New Drug Application Approval
004041 New Drug Application Approval
004122 New Drug Application Approval New manufacturer (S) Standard review drug
005509 New Drug Application Approval
005521 New Drug Application Approval
005725 New Drug Application Approval
006135 New Drug Application Approval
006213 New Drug Application Approval
006317 New Drug Application Approval
006325 New Drug Application Approval New manufacturer (S) Standard review drug
006460 New Drug Application Approval New manufacturer (S) Standard review drug
006470 New Drug Application Approval New manufacturer (S) Standard review drug
006632 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
007245 New Drug Application Approval New combination (S) Standard review drug
007392 New Drug Application Approval New ester, new salt, or other noncovalent derivative (S) Standard review drug
007529 New Drug Application Approval New ester, new salt, or other noncovalent derivative (P) Priority review drug
007865 New Drug Application Approval New formulation (S) Standard review drug
008499 New Drug Application Approval New manufacturer (S) Standard review drug
008869 New Drug Application Approval New molecular entity (NME); New combination (S) Standard review drug
008951 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
009238 New Drug Application Approval New manufacturer (S) Standard review drug
009344 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
009376 New Drug Application Approval New manufacturer (S) Standard review drug
010012 New Drug Application Approval New manufacturer (S) Standard review drug
012122 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
012665 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
012772 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
012928 New Drug Application Approval New formulation (S) Standard review drug
012936 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
013157 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
013378 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
014103 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
014684 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
017820 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
017931 New Drug Application Approval New manufacturer (S) Standard review drug
017932 New Drug Application Approval New manufacturer (S) Standard review drug
017936 New Drug Application Approval New manufacturer (S) Standard review drug
018067 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
018344 New Drug Application Approval New formulation (P) Priority review drug
018345 New Drug Application Approval New formulation (P) Priority review drug
018346 New Drug Application Approval New formulation (P) Priority review drug
018347 New Drug Application Approval New formulation (P) Priority review drug
018476 New Drug Application Approval New formulation (S) Standard review drug
018477 New Drug Application Approval New formulation (S) Standard review drug
018478 New Drug Application Approval New formulation (S) Standard review drug
018479 New Drug Application Approval New formulation (S) Standard review drug
018780 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
018781 New Drug Application Approval New formulation (S) Standard review drug
019377 New Drug Application Approval New manufacturer (S) Standard review drug
019529 New Drug Application Approval New formulation (S) Standard review drug
019571 New Drug Application Approval New formulation (S) Standard review drug
019640 New Drug Application Approval New manufacturer (P) Priority review drug (V) Orphan drug
019693 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
019717 New Drug Application Approval New manufacturer (S) Standard review drug
020100 New Drug Application Approval New formulation (S) Standard review drug
020101 New Drug Application Approval New formulation (P) Priority review drug
020509 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
020563 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020592 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020815 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
020928 New Drug Application Approval New formulation (P) Priority review drug
020974 New Drug Application Approval New formulation (S) Standard review drug
021017 New Drug Application Approval New formulation; New combination (S) Standard review drug
021018 New Drug Application Approval New formulation; New combination (S) Standard review drug
021086 New Drug Application Approval New formulation (S) Standard review drug
021235 New Drug Application Approval New formulation (S) Standard review drug
021253 New Drug Application Approval New formulation (S) Standard review drug
021318 New Drug Application Approval New formulation (S) Standard review drug
021368 New Drug Application Approval New molecular entity (NME)
021411 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
021427 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
021462 New Drug Application Approval New molecular entity (NME) (P) Priority review drug (V) Orphan drug
021520 New Drug Application Approval New combination (P) Priority review drug
021677 New Drug Application Approval New indication (S) Standard review drug
021733 New Drug Application Approval New indication (P) Priority review drug
022042 New Drug Application Approval New indication (S) Standard review drug (V) Orphan drug
022148 New Drug Application Approval New indication (S) Standard review drug
022516 New Drug Application Approval New indication (S) Standard review drug
050010 New Drug Application Approval
050219 New Drug Application Approval
050345 New Drug Application Approval
050346 New Drug Application Approval
050440 New Drug Application Approval
050477 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
050482 New Drug Application Approval New formulation (S) Standard review drug
050504 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
050519 New Drug Application Approval New formulation (S) Standard review drug
050521 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
050522 New Drug Application Approval New ester, new salt, or other noncovalent derivative (S) Standard review drug
050532 New Drug Application Approval New formulation (S) Standard review drug
050550 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
050599 New Drug Application Approval New combination (S) Standard review drug
050614 New Drug Application Approval New formulation (S) Standard review drug
050673 New Drug Application Approval New formulation (S) Standard review drug
060002 Abbreviated New Drug Application Approval
060003 Abbreviated New Drug Application Approval
060004 Abbreviated New Drug Application Approval
060093 Abbreviated New Drug Application Approval
060107 Abbreviated New Drug Application Approval
060384 Abbreviated New Drug Application Approval
060385 Abbreviated New Drug Application Approval
060403 Abbreviated New Drug Application Approval
060404 Abbreviated New Drug Application Approval
060601 Abbreviated New Drug Application Approval
060687 Abbreviated New Drug Application Approval
061894 Abbreviated New Drug Application Approval
061896 Abbreviated New Drug Application Approval
061897 Abbreviated New Drug Application Approval
062008 Abbreviated New Drug Application Approval
062549 Abbreviated New Drug Application Approval
062557 Abbreviated New Drug Application Approval
062560 Abbreviated New Drug Application Approval
062565 Abbreviated New Drug Application Approval
062590 Abbreviated New Drug Application Approval
062592 Abbreviated New Drug Application Approval
062655 Abbreviated New Drug Application Approval
062707 Abbreviated New Drug Application Approval
062739 Abbreviated New Drug Application Approval
062745 Abbreviated New Drug Application Approval
080254 Abbreviated New Drug Application Approval
080256 Abbreviated New Drug Application Approval
080853 Abbreviated New Drug Application Approval
080854 Abbreviated New Drug Application Approval
080855 Abbreviated New Drug Application Approval
080883 Abbreviated New Drug Application Approval
080884 Abbreviated New Drug Application Approval
084100 Abbreviated New Drug Application Approval
085038 Abbreviated New Drug Application Approval
085103 Abbreviated New Drug Application Approval
086530 Abbreviated New Drug Application Approval
125029 Biologic License Application Approval

Back to Companies who have applied for FDA Drug Approval